世界のポナチニブ市場予測2023-2029：45mg、15mg

【英語タイトル】Ponatinib Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8579
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：77
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のポナチニブ市場規模と予測を収録しています。・世界のポナチニブ市場：売上、2018年-2023年、2024年-2029年
・世界のポナチニブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のポナチニブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「45mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ポナチニブのグローバル主要企業は、ARIAD Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ポナチニブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のポナチニブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のポナチニブ市場：タイプ別市場シェア、2022年
・45mg、15mg

世界のポナチニブ市場：用途別、2018年-2023年、2024年-2029年
世界のポナチニブ市場：用途別市場シェア、2022年
・CML、オール

世界のポナチニブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のポナチニブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるポナチニブのグローバル売上、2018年-2023年
・主要企業におけるポナチニブのグローバル売上シェア、2022年
・主要企業におけるポナチニブのグローバル販売量、2018年-2023年
・主要企業におけるポナチニブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
ARIAD Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
ポナチニブ市場の定義
市場セグメント
世界のポナチニブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のポナチニブ市場規模
世界のポナチニブ市場規模：2022年 VS 2029年
世界のポナチニブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのポナチニブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のポナチニブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：45mg、15mg
ポナチニブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：CML、オール
ポナチニブの用途別グローバル売上・予測

・地域別市場分析
地域別ポナチニブ市場規模 2022年と2029年
地域別ポナチニブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
ARIAD Pharmaceuticals
...

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
This report aims to provide a comprehensive presentation of the global market for Ponatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ponatinib. This report contains market size and forecasts of Ponatinib in global, including the following market information:
Global Ponatinib Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ponatinib Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ponatinib companies in 2022 (%)
The global Ponatinib market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
45mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ponatinib include ARIAD Pharmaceuticals. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ponatinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ponatinib Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ponatinib Market Segment Percentages, by Type, 2022 (%)
45mg
15mg
Global Ponatinib Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ponatinib Market Segment Percentages, by Application, 2022 (%)
CML
ALL
Global Ponatinib Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ponatinib Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ponatinib revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ponatinib revenues share in global market, 2022 (%)
Key companies Ponatinib sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ponatinib sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ARIAD Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ponatinib, market overview.
Chapter 2: Global Ponatinib market size in revenue and volume.
Chapter 3: Detailed analysis of Ponatinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ponatinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ponatinib capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Ponatinib Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ponatinib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ponatinib Overall Market Size
2.1 Global Ponatinib Market Size: 2022 VS 2029
2.2 Global Ponatinib Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ponatinib Sales: 2018-2029
3 Company Landscape
3.1 Top Ponatinib Players in Global Market
3.2 Top Global Ponatinib Companies Ranked by Revenue
3.3 Global Ponatinib Revenue by Companies
3.4 Global Ponatinib Sales by Companies
3.5 Global Ponatinib Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ponatinib Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ponatinib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ponatinib Players in Global Market
3.8.1 List of Global Tier 1 Ponatinib Companies
3.8.2 List of Global Tier 2 and Tier 3 Ponatinib Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ponatinib Market Size Markets, 2022 & 2029
4.1.2 45mg
4.1.3 15mg
4.2 By Type – Global Ponatinib Revenue & Forecasts
4.2.1 By Type – Global Ponatinib Revenue, 2018-2023
4.2.2 By Type – Global Ponatinib Revenue, 2024-2029
4.2.3 By Type – Global Ponatinib Revenue Market Share, 2018-2029
4.3 By Type – Global Ponatinib Sales & Forecasts
4.3.1 By Type – Global Ponatinib Sales, 2018-2023
4.3.2 By Type – Global Ponatinib Sales, 2024-2029
4.3.3 By Type – Global Ponatinib Sales Market Share, 2018-2029
4.4 By Type – Global Ponatinib Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ponatinib Market Size, 2022 & 2029
5.1.2 CML
5.1.3 ALL
5.2 By Application – Global Ponatinib Revenue & Forecasts
5.2.1 By Application – Global Ponatinib Revenue, 2018-2023
5.2.2 By Application – Global Ponatinib Revenue, 2024-2029
5.2.3 By Application – Global Ponatinib Revenue Market Share, 2018-2029
5.3 By Application – Global Ponatinib Sales & Forecasts
5.3.1 By Application – Global Ponatinib Sales, 2018-2023
5.3.2 By Application – Global Ponatinib Sales, 2024-2029
5.3.3 By Application – Global Ponatinib Sales Market Share, 2018-2029
5.4 By Application – Global Ponatinib Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ponatinib Market Size, 2022 & 2029
6.2 By Region – Global Ponatinib Revenue & Forecasts
6.2.1 By Region – Global Ponatinib Revenue, 2018-2023
6.2.2 By Region – Global Ponatinib Revenue, 2024-2029
6.2.3 By Region – Global Ponatinib Revenue Market Share, 2018-2029
6.3 By Region – Global Ponatinib Sales & Forecasts
6.3.1 By Region – Global Ponatinib Sales, 2018-2023
6.3.2 By Region – Global Ponatinib Sales, 2024-2029
6.3.3 By Region – Global Ponatinib Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ponatinib Revenue, 2018-2029
6.4.2 By Country – North America Ponatinib Sales, 2018-2029
6.4.3 US Ponatinib Market Size, 2018-2029
6.4.4 Canada Ponatinib Market Size, 2018-2029
6.4.5 Mexico Ponatinib Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ponatinib Revenue, 2018-2029
6.5.2 By Country – Europe Ponatinib Sales, 2018-2029
6.5.3 Germany Ponatinib Market Size, 2018-2029
6.5.4 France Ponatinib Market Size, 2018-2029
6.5.5 U.K. Ponatinib Market Size, 2018-2029
6.5.6 Italy Ponatinib Market Size, 2018-2029
6.5.7 Russia Ponatinib Market Size, 2018-2029
6.5.8 Nordic Countries Ponatinib Market Size, 2018-2029
6.5.9 Benelux Ponatinib Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ponatinib Revenue, 2018-2029
6.6.2 By Region – Asia Ponatinib Sales, 2018-2029
6.6.3 China Ponatinib Market Size, 2018-2029
6.6.4 Japan Ponatinib Market Size, 2018-2029
6.6.5 South Korea Ponatinib Market Size, 2018-2029
6.6.6 Southeast Asia Ponatinib Market Size, 2018-2029
6.6.7 India Ponatinib Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ponatinib Revenue, 2018-2029
6.7.2 By Country – South America Ponatinib Sales, 2018-2029
6.7.3 Brazil Ponatinib Market Size, 2018-2029
6.7.4 Argentina Ponatinib Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ponatinib Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ponatinib Sales, 2018-2029
6.8.3 Turkey Ponatinib Market Size, 2018-2029
6.8.4 Israel Ponatinib Market Size, 2018-2029
6.8.5 Saudi Arabia Ponatinib Market Size, 2018-2029
6.8.6 UAE Ponatinib Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ARIAD Pharmaceuticals
7.1.1 ARIAD Pharmaceuticals Company Summary
7.1.2 ARIAD Pharmaceuticals Business Overview
7.1.3 ARIAD Pharmaceuticals Ponatinib Major Product Offerings
7.1.4 ARIAD Pharmaceuticals Ponatinib Sales and Revenue in Global (2018-2023)
7.1.5 ARIAD Pharmaceuticals Key News & Latest Developments
8 Global Ponatinib Production Capacity, Analysis
8.1 Global Ponatinib Production Capacity, 2018-2029
8.2 Ponatinib Production Capacity of Key Manufacturers in Global Market
8.3 Global Ponatinib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ponatinib Supply Chain Analysis
10.1 Ponatinib Industry Value Chain
10.2 Ponatinib Upstream Market
10.3 Ponatinib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ponatinib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Ponatinib in Global Market
Table 2. Top Ponatinib Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ponatinib Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ponatinib Revenue Share by Companies, 2018-2023
Table 5. Global Ponatinib Sales by Companies, (K Units), 2018-2023
Table 6. Global Ponatinib Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ponatinib Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Ponatinib Product Type
Table 9. List of Global Tier 1 Ponatinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ponatinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Ponatinib Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Ponatinib Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ponatinib Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Ponatinib Sales (K Units), 2018-2023
Table 15. By Type - Global Ponatinib Sales (K Units), 2024-2029
Table 16. By Application – Global Ponatinib Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Ponatinib Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ponatinib Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Ponatinib Sales (K Units), 2018-2023
Table 20. By Application - Global Ponatinib Sales (K Units), 2024-2029
Table 21. By Region – Global Ponatinib Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Ponatinib Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ponatinib Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Ponatinib Sales (K Units), 2018-2023
Table 25. By Region - Global Ponatinib Sales (K Units), 2024-2029
Table 26. By Country - North America Ponatinib Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ponatinib Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Ponatinib Sales, (K Units), 2018-2023
Table 29. By Country - North America Ponatinib Sales, (K Units), 2024-2029
Table 30. By Country - Europe Ponatinib Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ponatinib Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Ponatinib Sales, (K Units), 2018-2023
Table 33. By Country - Europe Ponatinib Sales, (K Units), 2024-2029
Table 34. By Region - Asia Ponatinib Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ponatinib Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Ponatinib Sales, (K Units), 2018-2023
Table 37. By Region - Asia Ponatinib Sales, (K Units), 2024-2029
Table 38. By Country - South America Ponatinib Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ponatinib Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Ponatinib Sales, (K Units), 2018-2023
Table 41. By Country - South America Ponatinib Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Ponatinib Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ponatinib Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Ponatinib Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Ponatinib Sales, (K Units), 2024-2029
Table 46. ARIAD Pharmaceuticals Company Summary
Table 47. ARIAD Pharmaceuticals Ponatinib Product Offerings
Table 48. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. ARIAD Pharmaceuticals Key News & Latest Developments
Table 50. Ponatinib Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Ponatinib Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Ponatinib Production by Region, 2018-2023 (K Units)
Table 53. Global Ponatinib Production by Region, 2024-2029 (K Units)
Table 54. Ponatinib Market Opportunities & Trends in Global Market
Table 55. Ponatinib Market Drivers in Global Market
Table 56. Ponatinib Market Restraints in Global Market
Table 57. Ponatinib Raw Materials
Table 58. Ponatinib Raw Materials Suppliers in Global Market
Table 59. Typical Ponatinib Downstream
Table 60. Ponatinib Downstream Clients in Global Market
Table 61. Ponatinib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ponatinib Segment by Type in 2022
Figure 2. Ponatinib Segment by Application in 2022
Figure 3. Global Ponatinib Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ponatinib Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ponatinib Revenue, 2018-2029 (US$, Mn)
Figure 7. Ponatinib Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ponatinib Revenue in 2022
Figure 9. By Type - Global Ponatinib Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Ponatinib Revenue Market Share, 2018-2029
Figure 11. By Type - Global Ponatinib Sales Market Share, 2018-2029
Figure 12. By Type - Global Ponatinib Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Ponatinib Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Ponatinib Revenue Market Share, 2018-2029
Figure 15. By Application - Global Ponatinib Sales Market Share, 2018-2029
Figure 16. By Application - Global Ponatinib Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Ponatinib Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Ponatinib Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Ponatinib Revenue Market Share, 2018-2029
Figure 20. By Region - Global Ponatinib Sales Market Share, 2018-2029
Figure 21. By Country - North America Ponatinib Revenue Market Share, 2018-2029
Figure 22. By Country - North America Ponatinib Sales Market Share, 2018-2029
Figure 23. US Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Ponatinib Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Ponatinib Sales Market Share, 2018-2029
Figure 28. Germany Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 29. France Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Ponatinib Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Ponatinib Sales Market Share, 2018-2029
Figure 37. China Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 41. India Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Ponatinib Revenue Market Share, 2018-2029
Figure 43. By Country - South America Ponatinib Sales Market Share, 2018-2029
Figure 44. Brazil Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Ponatinib Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Ponatinib Sales Market Share, 2018-2029
Figure 48. Turkey Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Ponatinib Revenue, (US$, Mn), 2018-2029
Figure 52. Global Ponatinib Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Ponatinib by Region, 2022 VS 2029
Figure 54. Ponatinib Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界のポナチニブ市場予測2023-2029：45mg、15mg] (コード：MMG23LY8579)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のポナチニブ市場予測2023-2029：45mg、15mg]についてメールでお問い合わせ

MarketReport.jp

世界のポナチニブ市場予測2023-2029：45mg、15mg

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp